Congressional Cannabis Caucus Pushes Full Legalization Beyond Rescheduling

Congressional Democrats are ramping up pressure for comprehensive federal marijuana legalization, arguing that the Trump administration's rescheduling efforts fall short of the sweeping reform voters demand. Rep. Ilhan Omar (D-MN), co-chair of the Congressional Cannabis Caucus, led a press conference Wednesday calling for federal policy to align with public opinion, which consistently shows majority support for full legalization across party lines.

The timing creates a stark policy contrast as the incoming Trump administration appears focused on moving cannabis from Schedule I to Schedule III under the Controlled Substances Act. While rescheduling would reduce federal penalties and enable tax deductions for cannabis businesses under Section 280E, it maintains federal prohibition and leaves state-legal operators in regulatory limbo. This incremental approach disappoints industry advocates who argue that partial reform creates more compliance burdens without delivering the banking access and interstate commerce benefits that full legalization would provide.

The political dynamics highlight the cannabis industry's regulatory uncertainty heading into 2025. Multi-state operators like Curaleaf (OTCQX: CURLF) and Green Thumb Industries (OTCQX: GTBIF) have built business models around state-by-state expansion, but federal prohibition limits their access to traditional banking and capital markets. Full legalization would unlock institutional investment and enable these companies to operate like normal businesses, potentially driving significant multiple expansion across the sector.

Congressional Cannabis Caucus members face an uphill battle with Republicans controlling both chambers, but shifting public opinion creates leverage for future negotiations. Recent polling shows 70% of Americans support marijuana legalization, including growing support among conservative voters in red states that have approved medical or recreational programs. This voter pressure could force Republican lawmakers to address cannabis policy, particularly as states continue generating substantial tax revenue from legal sales.

The disconnect between federal prohibition and state legalization creates ongoing challenges for cannabis companies trading on over-the-counter markets rather than major exchanges. While rescheduling would provide immediate tax relief, comprehensive reform remains the industry's preferred outcome for unlocking its full economic potential. The Congressional push signals that federal cannabis policy will remain a contentious issue, with Democrats positioning themselves as champions of full legalization against more cautious Republican approaches.